Zusammenfassung
Die Therapie der Schilddrüse mit Radiojod ist eine strahlentherapeutische Methode, welche unter Anwendung der Atomkernenergie abnorme Funktionszustände beheben und normale oder pathologische Strukturen zerstören, zurückdrängen oder im Wachstum hemmen soll. Die im Atomkern eingeschlossene Energie wird beim radioaktiven Zerfall unter Aussendung energiereicher Korpuskular- und elektromagnetischer Wellenstrahlen frei. Die emittierten Strahlen sind befähigt, die Atome und Moleküle der Materie zu ionisieren und im Organismus mannigfache biologische Wirkungen hervorzurufen. Bei gezielter Anwendung und richtiger Dosierung können sie erstaunliche Heilwirkungen, bei unsachgemäßer Handhabung schwerste irreversible Schäden im bestrahlten Organismus hervorrufen. Die gezielte, allein auf den Krankheitsherd beschränkte Auslösung dieser destruktiven Wirkungen bildet die unerläßliche Voraussetzung für eine therapeutische Anwendung der energiereichen Strahlen. Beim Radio jod wird diese Vorbedingung in nahezu idealer Weise auf dem Stoffwechselweg erfüllt. Die Durchführung einer rationellen Therapie, die sich auf dem wissenschaftlichen Verständnis und der ärztlich begründeten Anwendung der ionisierenden Energie aufbaut, setzt nicht nur gesicherte Kenntnisse über die kernphysikalischen und strahlenbiologischen Grundlagen, sondern auch über die physiologischen und pathologischen Gesetzmäßigkeiten des Jodstoffwechsels sowie klinische Erfahrungen in der Erkennung und Behandlung der Schilddrüsenkrankheiten voraus.
Aus der Medizinischen Universitätsklinik Freiburg i. Br. (Direktor: Prof. Dr. Dr. h. c. L. Heilmeyer).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Abelin, I., U. G. Perotti: Über die Speicherung des Broms durch die Thyreoidea. Schweiz, med. Wschr. 1952, 1186.
Ackermann, P. G., and K. Iversen: Radio-iodine excretion in the aged. J. of Gerontol. 8, 458 (1953).
Albert, A.: Effects of altered thyroid function upon the metabolism of endogenously labeled hormone. J. Clin. Endocrin. 13, 880 (1953).
Albert, A. and N. Lorenz: The effect of hypophysectomy on the intrathvroidal metabolism of I131. Proc. Soc. Exper. Biol. a. Med. 77, 204 (1951).
Albright, E. C., F. C. Larson and W. P. Deiss: Thyroxine binding capacity of serum alpha globulin in hypothyroid, euthyroid, and hyperthyroid subjects. J. Clin. Invest. 34, 44 (1955).
Allen, M. S., H. H. Dunham, Ch. E. Montgomery and E. T. Siler: The treatment of hyperthyroidism with radioactive iodine I131. J. Kansas Med. Soc. 54, 120 (1953).
Allen, H. C., Jr., and W. E. Goodwin: The scintillation counter as an instrument for in vivo determination of thyroid weight. Radiology 58, 68 (1952).
Allen, H. C., Jr., R. L. Libby and B. Cassen: The scintillation counter in clinical studies of human thyroid physiology using I131. J. Clin. Endocrin. 11, 492 (1951).
Anderson, B. G.: Treatment of recurrent hyperthyroidism with radioactive iodine. Metabolism (N. Y.) 3, 297 (1954).
Andrews, G. A.: Pathologic changes in normal human thyroid tissue following large doses of I131. Amer. J. Med. (N. Y.) 16, 372 (1954).
Ansell, G., and H. Miller: Influence of iodine on the release of thyroid hormone in thyrotoxicosis. Lancet 1952 II, 5–10.
Arnott, D. G., E. Wt. Emery, R. Fraser and Q. J. G. Hobson: Urinary excretion of radioactive iodine as a diagnostic test in thyroid disease. Lancet 1949 II, 460.
Asper, S. P., H. A. Selenkow and C. A. Plamondon: A comparison of the metabolic activities of 3:5:3’-1-triiodothyronine and 1-thyroxine in myxedema. Bull. Johns Hopkins Hosp. 93, 164 (1953).
Balint, J. A., R. Fräser and M. G. W. Hanno: Radio-iodine measurements of thyroid function during and after P. A. S. treatment of tuberculosis. Brit. Med. J. 1954, 1234.
Balls, K. F., R. H. Chamberlain, E. Rose, R. O. Gorson and H. C. Blount: The treatment of thyrotoxicosis with radioiodine. Radiology 64, 858 (1955).
Balme, H. W.: Metastatic carcinoma of the thyroid successfully treated with thyroxine. Lancet 1954 I, 812–813.
Bansi, H. W.: Thyreotoxikosen und antithyreoidale Substanzen. Stuttgart: Georg Thieme 1951.
Bansi, H. W.: Jodstoffwechsel, Schilddrüse und Hypophysen vor der läppen. Klin. Wschr. 1951, 33.
Bansi, H. W.: “Jod” in Künstliche Radioaktive Isotope in Physiologie, Diagnostik und Therapie. Berlin-Göttingen-Heidelberg: Springer-Verlag 1953.
Bansi, H. W.: Krankheiten der Schilddrüse. Im Handbuch der inneren Medizin, 4. Aufl., Bd. VII, 1. Teil. Berlin-Göttingen-Heidelberg: Springer-Verlag 1955.
Barrett, T. F., H. Peck, F. K. Bauer, R. L. Libby and S. R. Jarrett: Evaluation of a thyroid panel. Practical application of scintiLations counter in diagnosis of diseases of the thyroid. J. Amer. Med. Assoc. 152, 1414 (1953).
Bartels, E. C.: Postthyroidectomy myxedema after properative use of antithyroid drugs. J. Clin. Endocrin. 13, 95 (1953).
Bauer, F. K.: I131 uptake in treated hyperthyroidism. Amer. J. Med. Sci. 223, 495 (1952).
Bauer, F. K., W. E. Goodwin, R. L. Libby U. B. Cassen: Visual delineation of thyroid glands in vivo. J. Labor, a. Clin. Med. 39, 153 (1952).
Bauer, F. K., W. E. Goodwin, R. L. Libby U. B. Cassen: The diagnosis of morphologic abnormalities of the human thyroid gland by means of I131. Radiology 61, 935 (1953).
Baumann, E. J.: Über das normale Vorkommen des Jods im Tierkörper. III. Der Jodgehalt der Schilddrüsen von Menschen und Tieren. Z. physiol. Chem. 22, 1 (1896).
Baumeister, C. F.: Radioiodine tracer and biopsy in the diagnosis and treatment of hyper-thyroidism. Arch. Surg. 67, 80 (1953).
Becker, D. V., J. E. Rall, W. Peacock and R. W. Rawson: The effect of a thyrotrophs hormone preparation on the metabolism of radioiodine in euthyroid, hyperthyroid and acromegalic individuals. J. Clin. Invest. 32, 149 (1953).
Beierwaltes, W. H.: Indications and contraindications for treatment of thyroid cancer with radioactive iodine. Ann. Int. Med. 37, 23 (1952).
Berkman, A. T.: Progressive exophthalmos following thyroidectomy cured by irradiation of the cerebral centers. Radiology 62, 406 (1954).
Berkson, J., F. R. Keating Jr., M. H. Power and W. M. Mcconahey: Determination of renal clearance of radioiodine. J. Appl. Physiol. 2, 522 (1950).
Bernert, T., R. Seyss U. E. Witt: Messungen mit Radiojod in der Aerosoltherapie. Med. Klin. 1951, 1362.
Berson, S. A., and R. S. Yalow: The effect of cortisone on the iodine accumulation function of the thyroid gland in euthyroid subjects. J. Clin. Endocrin. 12, 407 (1952).
Berson, S. A., J. Sorrentino and B. Roswit: Determination of thyroidal plasma iodide clearance as a routine diagnostic test of thyroid function. Bull. New York Acad. Med. 27, 395 (1951).
Berson, S. A., J. Sorrentino and B. Roswit: The determination of thyroidal and renal plasma I131 clearance rates as a routine diagnostic test of thyroid dysfunction. J. Clin. Invest. 31, 141 (1952).
Bertelsen, A., E. Christensen, E. Bruun and P. Becker-Christensen: Mortality, operative complications and recurrence frequency in the surgical treatment of thyrotoxicosis. Acta chir. scand. (Stockh.) 96, 133 (1947), Suppl.
Beutel, A.: Der Blutcholesterinspiegel als Indikator der strahlentherapeutischen Beeinflussung der Hyperthyreosen. Strahlenther. 69, 400 (1951).
Billion, H.: Radiojod zur Schilddrüsenbehandlung. Ärztl. Wschr. 1950, 689.
Billion, H.: Fortschritte in der Radiojoddiagnostik und-therapie. Strahlenther. 47, 78 (1955).
Billion, H., U. P. Kühne: Der Wert verschiedener Radiojodtestverfahren für die Differentialdiagnostik von Schilddrüsenfunktionsstörungen. (Mit einem Beitrag zur “aktiven Hyperplasie”.) Z. klin. Med. 152, 411 (1954).
Billion, H., K. Oeff U. F. Klauer: Ergebnisse mit dem Radiojod-Test der Schilddrüse. Ärztl. Wschr. 1951, 306.
Birkhill, F. R., K. E. Corrigan and H. S. Hayden: The metabolism of radioactive iodine (I131) in patients with cardiac disease. Amer. J. Roentgenol. 67, 42 (1952).
Black, B. M.: Surgical treatment of carcinoma of the thyroid gland. J. Clin. Endocrin. 9, 1422 (1949).
Black, B. M., L. B. Woolner and Ch. M. Blackburn: The uptake of radioactive iodine by carcinoma of the thyroid gland: A study of 128 cases. J. Clin. Endocrin. 13, 1378 (1953).
Blackburn, Ch. M., and M. H. Power: Diagnostic accuracy of serum protein bound iodine determination in thyroid disease. J. Clin. Endocrin. 15, 1379 (1955).
Blomfield, G. W., J. C. Jones, A. G. Macgregor, H. Miller and E. J. Wayne: Treatment of thyrotoxicosis with radioactive iodine. Brit. Med. J. 19511, 373.
Blumgart, H. L., and D. D. Berlin: Therapeutic effect of ablative of normal thyroid on congestive heart failure and angina pectoris. Arch. Int. Med. 51, 866 (1933).
Blumgart, H. L., D. Davis, J. E. F. Riseman and A. A. Weinstein: Treatment of angina pectoris and congestive heart failure by total ablation of the thyroid in patients without thyro-toxicosis. Ann. Int. Med. 7, 1449 (1933/34).
Blumgart, H. L., and A. St. Freedberg: The heart and the thyroid: With particular reference to I131 treatment of heart disease. Circulation (New York) 6, 222 (1952).
Blumgart, H. L., and R. Buka: Treatment of euthyroid cardiac patients by producing myxedema with radioactive iodine. Proc. Soc. Exper. Biol. a. Med. 67, 190 (1948).
Blumgart, H. L., and G. S. Kurland: Hypothyroidism produced by radioactive iodine (I131) in the treatment of euthyroid patients with angina pectoris and congestive heart failure. Circulation (New York) 1, 1105 (1950).
Blumgart, H. L., and G. S. Kurland: Treatment of incapacitated euthyroid cardiac patients by producing hypo-thyroidism with radioactive iodine. New England J. Med. 245, 83 (1951).
Blumgart, H. L., and G. S. Kurland: Treatment of incapacitated euthyreoid cardiac patients with radioactive iodine. J. Amer. Med. Assoc. 157, 1 (1955).
Blumgart, H. L., S. A. Levine and D. D. Berlin: Congestive heart failure and angina pectoris: The therapeutic effect of thyroidectomy on patients without clinical or pathologic evidence of thyroid toxicity. Arch. Int. Med. 51, 866 (1933).
Boatman, J. B., and C. Moses: Role of erythrocyte in blood iodine transport using radio-iodine I131. Amer. J. Physiol. 164, 783 (1951).
Bondy, P. K., and M. A. Hagewood: Effect of stress and cortisone on plasma protein-bound iodine and thyroxine metabolism in rats. Proc. Soc. Exper. Biol. a. Med. 81, 328 (1952).
Bondy, P. K., and M. A. Hagewood: Effect of stress and cortisone on plasma protein-bound iodine and thyroxine metabolism in rats. Proc. Soc. Exper. Biol. a. Med. 81, 328 (1952).
Botkin, A. L., and H. Jensen: The effect of epinephrine and thyrotropin on thyroid function in rats. Endocrinology (Springfield, 111.) 50, 68 (1952).
Botkin, A. L., and H. Jensen: The effect of epinephrine and thyrotropin on thyroid function in rats. Endocrinology (Springfield, 111.) 50, 68 (1952).
Brands, K., U. C. Montag: Die Beeinflussung der radioaktiven Jodspeicherung der Schilddrüse durch Keimdrüsenhormone. Arch. Geschwulstforsch. 6, 11 (1953).
Braun-Wotke, J.: Lungentuberkulose und Strumektomie. Wien. klin. Wschr. 1952, 836.
Brockman, D. D., and R. M. Whitman: Post-thyrodectomy psychoses. J. Nerv. Ment. Dis. 116, 340 (1952).
Brügel, H.: Die Behandlung der Thyreotoxikose mit radioaktivem Jod. Dtsch. med. Wschr. 1956, 135.
Burrows, B. A., T. Peters and J. F. Ross: The tissue utilization of endogenous: Thyroid hormone in human subjects. J. Clin. Invest. 33, 921 (1954).
Burrows, B. A., J. F. Ross, E. S. Dell, D. E. Graham and D. F. Hammack: The thyroidal uptake of stable iodine compared with the serum concentration of protein-bound iodine in normal subjects and in patients with thyroid disease. J. Clin. Endocrin. 13, 1358 (1953).
Cassen, B., L. Curtis, C. Reed and R. L. Libby: Instrumentation for I131 use in medical studies. Nucleonics 9, 46 (1951).
Catz, B., I. El Rawi and E. Geiger: Increased I131 collection by the thyroid of the rat in acute starvation. Amer. J. Physiol. 172, 291 (1953).
Chaikoff, I. L., and A. Taurog: Studies on the formation of organically bound iodine compounds in the thyroid gland and their appearance in plasma as shown by the use of radioactive iodine. Ann. N. Y. Acad Sci. 50, 379 (1949).
Chaikoff, I. L., and W. O. Reinhardt: The metabolic significance of protein-bound iodine of plasma: A study of its concentration under various conditions and of its rate of formation as measured with radioactive iodine. Endocrinology (Springfield, 111.) 40, 47 (1947).
Chapman, E. M.: Treatment of Graves’ disease with radioactive iodine. West. J. Surg. 56, 47 (1948).
Chapman, E. M.: Radioactive iodine in therapy of cancer of the thyroid. 2nd. National Cancer Conference Cincinnati, Ohio, March 3–5, 1952.
Chapman, E. M., G. W. Corner, D. Robinson and R. D. Evans: The collection of radioactive iodine by the human fetal thyroid. J. Clin. Endocrin. 8, 717 (1948).
Chapman, E. M., and R. D. Evans: The treatment of hyperthyroidism with radioactive iodine. J. Amer. Med. Assoc. 181, 86 (1946).
Chapman, E. M., and R. D. Evans: Treatment of toxic goiters with radioactive iodine. Med. Clin. N. Amer. 33. 1211 (1949).
Chapman, F. Maloof, J. Maisterrena and J. Martin: Ten years’ experience with radioactive iodide. J. Clin. Endocrin. 14, 45 (1954).
Chapman, F. Maloof, B. Skanse and R. D. Evans: Treatment of hyperthyroidism with radioactive iodine. Radiology 51, 558 (1948).
Chester, J., P. Lerch Et A. Vannotti: A propos du traitement par l’iode radioactif du cancer et des métastases d’origine thyroidienne. Schweiz. med. Wschr. 1950, 1377.
Chevalley, J., T. H. Mcgavack, S. Kenigsberg and S. Pearson: A four-year study of the treatment of hyperthyroidism with Methimazole. J. Clin. Endocrin. 14, 948 (1954).
Childs, D. S. Jr., F. R. Keating, J. E. Rall, M. M. D. Williams and M. H. Power: The effect of varying quantities of inorganic idodide (carrier) on the urinary excretion and thyroidal accumulation of radioiodine in exophthalmic goiter. J. Clin. Invest. 29, 726 (1950).
Clark, D. E., J. H. Rule, O. H. Trippel and D. A. Cofrin: Five year experience with radioactive iodine in treatment of hyperthyroidism. J. Amer. Med. Assoc. 150, 1269 (1952).
Clark, D. E., O. H. Trippel and G. E. Sheline: Diagnostic and therapeutic use of radioactive iodine. Arch. Int. Med. 87, 17 (1951).
Coliez, R., M. Tubiana, J. Dutreix Et J. Guelfi: Résultats du traitement de 43 cas de cancer du corps thyroide par l’iode radio-actif. J. de Radiol. 34, 305 (1953).
Cook, J. R., R. W. Jones and E. P. Mccullagh: Treatment of toxic adenomatous goiter by large doses of radioactive iodine. J. Clin. Endocrin. 15, 1512 (1955).
Corbett, B. D., and A. J. Honour: Design of directional counters for clinical use. Nucleonics 9, 43 (1951).
Crile, G.: Treatment of tumors of the thyroid with divided doses with radioactive iodine. Amer. J. Roentgenol. 65, 415 (1951).
Crile, G.: The danger of surgical dissemination of papillary carcinoma of the thyroid. Surg. etc. 102, 161 (1956).
Crile, G., and W. S. Dempsey: Indications for removal of nontoxic nodular goiters. J. Amer. Med. Assoc. 139, 1247 (1948).
Crile, G., and W. S. Dempsey: and E. P. MCCULLAGH: The treatment of hyperthyroidism. An evaluation of thyroid-ectomy, of prolonged administration of propylthiouracyl, and of radioactive iodine. Ann. Surg. 134, 18 (1951).
Crile, G., and W. S. Dempsey: and O. GLASSER: Experience with radioactive iodine in the treatment of hyper-thyroidism. Cleveland Clin. Quart. 16, 1 (1949).
Dailey, M. E., S. Lindsay and E. R. Miller: Histologic lesions in thyroid glands of patients receiving I131 for hyperthyroidism. J. Clin. Endocrin. a. Metabol. 13, 1513 (1953).
Dailey, M. E., M. H. Soley and S. Lindsay: Carcinoma of thyroid gland: A clinical and pathological study. Amer. J. Med. 9, 194 (1950).
Dargent, H., and P. Guinet: The early stages of thyroid carcinoma. Brit. Med. J. 1952, No. 4794, 1122.
Dargent, M., J. Papillon Et P. Guinet: La radiosensibilisation des épithéliomas thyroidiens par l’aminothiazol (Étude critique). J. de Radiol. 30, 15 (1949).
Deiss, W. P., E. C. Albright and F. C. Larson: A study of the nature of the circulating thyroid hormone in euthyroid and hyperthyroid subjects bv use of paper electrophoresis. J. Clin. Invest. 31, 1000 (1952).
Deiss, W. P., E. C. Albright and F. C. Larson: A study of the nature of the circulating thyroid hormone in euthyroid subjects by use of paper electrophoresis. J. Labor, a. Clin. Med. 40, 791 (1952).
Dobyns, B. M.: Radioactive iodine as an adjunct to the surgical management of diseases of the thyroid. Surg. etc. 93, 415 (1951).
Dobyns, B. M., and B. Lennon: A study of a histopathology and physiologic function of thyroid tumors, using radioactive iodine and radioautography. J. Clin. Endocrin. 8, 732 (1948).
Dobyns, B. M., and B. Lennon: and F. MALOOF: The study and treatment of 119 cases of carcinoma of the thyroid with radioactive iodine. J. Clin. Endocrin. 11, 1323 (1951).
Dobyns, B. M., and B. Lennon: B. SKANSE and F. MALOOF: A method for the preoperative estimation of function in thyroid tumors; its significance in diagnosis and treatment. J. Clin. Endocrin. 9, 1171 (1949).
Dobyns, B. M., and B. Lennon: and S. L. S. Eelman: The thyroid stimulating hormone of the anterior pituitary as distinct from the exophthalmos producing substance. Endocrinology (Springfield, 111.) 52, 705 (1953).
Dobyns, B. M., A. L. Vickery, F. Maloof and E. M. Chapman: Functional and histologic effects of therapeutic doses of radioactive iodine on the thyroid of man. J. Clin. Endocrin. 13, 548 (1953).
Doering, P.: Die Messung der Jodspeicherung in der menschlichen Schilddrüse nach Gabe von Radiojod (Jod131). Klin. Wschr. 1956, 837.
Doniach, I.: The effect of radioactive iodine alone and in combination with methylthiouracil upon tumor production in the rat’s thyroid gland. Brit. J. Cancer 7, 181 (1953).
Douglas, D. M., and A. T. Kennte: Thiouracil in toxic goiter; Late results in a personal series. Brit. Med. J. 1952 II, 1387.
Dunlop, D. M., and C. F. Rolland: Antithyroid substance in the treatment of hyperthy-roidism. Proc. Roy. Soc. Med. 43, 937 (1950).
Egmark, A., L. G. Larsson, A. Liljestrand and I. Ragnhult: Iodine concentrating thyroid carcinomas. A report of three cases. Acta radiol. (Stockh.) 39, 423 (1953).
Eichler, O., F. Hess, F. Linder U. K. Schmeiser: Zur Behandlung des Schilddrüsen-carcinoms mit Radiojod. Langenbecks Arch. 269, 19 (1951).
Eiff, A. W. V., U. H. J. Jesdinsky: Die Bestimmung des „Grundumsatzes im engeren Sinn„ in der Diagnostik der Thyreotoxikosen. Klin. Wschr. 1954, 317.
Eiff, A. W. V., U. H. J. Jesdinsky: u. W. MEYER-EPPLER: Elektromyointegrator, ein Gerät zur quantitativen Auswertung von Muskelaktionsströmen. Klin. Wschr. 1956, 484.
Engstrom, W. W., and B. Markardt: Influence of Estrogen on thyroid function. J. Clin. Endocrin. 14, 215 (1954).
Farquharson, R. F., and A. A. Squires: Inhibition of secretion of thyroid gland by continuous ingestion of substance. Trans. Assoc. Amer. Physicians 56, 87 (1941).
Fauvert, D., Et S. Nicollo: Traitement de l’hyperthvroide par l’iode radioactif (J131). Semaine Hop. 1954, 4236.
Feitelberg, S., P. S. Kaunitz, S. Silver, N. Simon, L. R. Wasserman and St. B. Yohalem: Hyperthyroidism, treatment with radioactive iodine. Arch. Int. Med. 85, 471 (1950).
Fellenberg, Th. V.: Vorkommen von Jod in der Natur: Zusammenhang zwischen Kropf-häufigkeit und Jodgehalt der Umwelt. Biochem. Z. 52, 148 (1924).
Fellinger, K, R. Höfer U. H. Vetter: Die Reproduzierbarkeit kurzzeitiger Radiojodunter-suchungen (Zugleich ein Beitrag zur klinischen Verwendung eines neuen radioaktiven Jodisotops J132). Wien. klin. Wschr. 1955, 712.
Fellinger, K, R. Höfer U. H. Vetter: E. MANNHEIMER U. H. VETTER: Zur Kenntnis der pathophysiologischen Grundlagen der Diagnostik und Therapie der Schilddrüsenerkrankungen mit radioaktivem Jod. Strahlenther., Sonderbd. 33, 81 (1955).
Fitting, W., U. A. W. V. Eiff: Über den diagnostischen Wert von Radiojodtest, Grundumsatz und “Grundumsatz im engeren Sinn” für die Beurteilung der Schilddrüsenfunktion. Klin. Wschr. 1956, 486.
Fitzgerald, P. J.: The histological types of thyroid cancers and their respective abilities to store radioactive iodine as demonstrated by radioautograms. Brookhaven, Conf. Report on radioactive iodine, July 28 /30 (1948).
Fitzgerald, P. J.: and F. W. FOOTE: The function of various types of thyroid carcinoma as revealed by the radioautographic demonstration of radioactive iodine (I131). J. Clin. Endocrin. 9, 1153 (1949).
Fitzgerald, P. J.: and R. F. HILL: Concentration of I131 in thyroid cancer shown by radioautography in 100 consecutive cases: The relation of histological structure to function of thyroid cancer. Cancer (N. Y.) 3, 86 (1950).
Frantz, V. K., R. P. Ball, A. S. Kesten and W. Wt. Palmer: Thyroid carcinoma with metastases, studied with radioactive iodine. Ann. Surg. 119, 668 (1944).
Frantz, V. K., R. P. Ball, A. S. Kesten and W. Wt. Palmer: W. G. LARSEN and A. JARETZKI: An evaluation of radioactive iodine therapy in metastatic thyroid cancer. J. Clin. Endocrin. 10, 1084 (1950).
Fräser, R., J. D. Abbatt and F. S. Stewart: Radioiodine treatment of thyrotoxicosis: A single dose method following a drug preparation. Brit. J. Radiol. 27, 23 (1954).
Fräser, R., Q. J. G. Hobson, D. G. Arnott and E. W. Emery: The urinary excretion of radioiodine as a clinical test of thyroid function. Q. art. J. Med. N. S. 22, 99 (1953).
Fräser, R., J. D. Abbatt and F. S. Stewart: E. H. QUIMBY and T. C. EVANS: Radioactive iodine studies of functional thyroid cancer. Radiology 51, 532 (1948).
Fredrickson, D. S., P. H. Forsham and G. W. Thorn: The effect of massive cortisone therapy on measurements of thyroid function. J. Clin. Endocrin. 12, 541 (1952).
Freedberg, A. S., D. L. Chamovitz and G. S. Kurland: Thyroid function in normal and pathological states as revealed by radioactive iodine studies. I. Thyroid I131 uptake and turnover in euthyroid, hyperthyroid and hypothyroid subjects. II. Factors influencing uptake and turnover of I131 by thyroid gland. Metabolism 1, 26–48 (1952).
Freedberg, A. S., D. L. Chamovitz and G. S. Kurland: G. S. KURLAND and H. L. BLUMGART: The pathologic effects of I131 on the normal thvroid gland of man. J. Clin. Endocrin. 12, 1315 (1952).
Freedberg, A. S., D. L. Chamovitz and G. S. Kurland: D. L. CHAMOVITZ and A. L. URELES: A critical analysis of the quantitative I131 therapy of thyrotoxicosis. J. Clin. Endocrin. 12, 86 (1952).
Freedberg, A. S., D. L. Chamovitz and G. S. Kurland: A. L. URELES and S. HERTZ: Serum level of protein-bound radioactive iodine (I131) in the diagnosis of hyperthyroidism. Proc. Soc. Exper. Biol. a. Med. 70, 679 (1949).
Freedberg, A. S., D. L. Chamovitz and G. S. Kurland: and B. SEAMON: The serum level of protein bound radioactive iodine (I131) in the diagnosis of hyperthyroidism. Proc. Soc. Exper. Biol. a. Med. 70, 697 (1949).
Freedberg, A. S., A. L. Ureles, M. F. Lesses and S. M. Gargill: Pulmonary metastatic lesion successfully treated with radioactive iodine. Report of a case of pulmonary metastases from a papillary adenocarcinoma of the thyroid. J. Amer. Med. Assoc. 144, 16 (1950).
Freedberg, A. S., A. L. Ureles, M. F. Lesses and S. M. Gargill: Treatment of thyroid carcinoma with radioactive iodine (I131). Amer. J. Med. 11, 44 (1951).
Freedberg, A. S., A. L. Ureles, M. F. Lesses and S. M. Gargill: L. WOLSKY, G. S. KURLAND and M. W. HAMOLSKY: The thyroid hormonal pool in man and dog. J. Clin. Invest. 31, 628 (1952).
Friedell, H. L., and A. M. Potts: I131 in the diagnosis and treatment of hyperthyroidism. Amer. J. Roentgenol. 64, 576 (1950).
Gerbaulet, K., U. W. Fitting: Über das Jod-Konzentrierungs-und Sekretionsvermögen der Speicheldrüsen (Untersucht mit Jod131 bei Patienten mit unterschiedlicher Schild-drüsenfunktion). Klin. Wschr. 1956, 120.
Gerbaulet, K., U. W. Maurer: Papierelektrophoretische und papierchromatographische Untersuchungen der organischen Jod-Verbindungen des Serums. Strahlenther., Sonderbd. 33, 116 (1955).
Ghosh, B. N., D. M. Woodbury and G. Sayers: Quantitative effects of thyrotropic hormone on I131 accumulation in thyroid and plasma proteins of hypophysectomized rats. Endo-crinology (Springfield, 111.) 48, 631 (1951).
Godley, A. F., and J. B. Stanbury: Preliminary experience in the treatment of hyper-thyroidism with Potassium Perchlorate. J. Clin. Endocrin. 14, 70 (1954).
Goodwin, J. F., B. J. Duffy, P. J. Fitzgerald, I. B. Trunnell and R. W. Rawson: Pathological effects and radioautographic localization of I131 in humans. Post mortem study in nine patients. Cancer (N. Y.) 4, 936 (1951).
Goldberg, R. C., and I. L. Chaikoff: On the nature of the hypertrophied pituitary gland induced in the mouse by I131 injections, and the mechanism of its development. Endocrinology (Springfield, 111.) 48, 1 (1951).
Goldberg, R. C., and I. L. Chaikoff: Development of thyroid neoplasms in the rat following a simple injection of radio-active iodine. Proc. Soc. Exper. Biol. a. Med. 76, 563 (1951).
Goldberg, R. C., S. Lindsay and D. D. Feller: Histopathological changes induced in the normal thyroid and other tissues of the rat by internal radiation with various doses of radioactive iodine. Endocrinology (Springfield, 111.) 46, 72 (1950).
Goldsmith, R. E.: Experience with the radioiodine tracer test in radioiodine-treated thyro-toxic patients. Amer. J. Med. Sci. 227, 403 (1954).
Goldsmith, R. E., and E. L. Saenger: Results of therapy with radioactive iodine in hyperthyroidism. Ohio State Med. J. 50, 26 (1954).
Goldsmith, R. E., J. B. Stanbury and G. L. Brownell: The effect of thyrotropin on the release of hormone from the human thyroid. J. Clin. Endocrin. 11, 1079 (1951).
Goodwin, J. F., A. G. Macgregor, H. Miller and E. J. Wayne: The use of radioactive iodine in the assessment of thyroid function. Quart. J. Med. N. S. 20, 353 (1951).
Goodwin, J. F., H. Miller and E. J. Wayne: A comparison of the antithyroid activity of paraamino-bezoic acid and thiouracil compounds. Lancet 1949 II, 1211.
Goodwin, W. E.: Total accountable radioiodine. Combined thyroid uptake and urinary excretion of I131 in the study of thyroid function. Metabolism 2, 238 (1953).
Goodwin, W. E., B. Cassen and F. K. Bauer: Thyroid gland weight determinations from thyroid scinti-grams with post mortem verification. Radiology 61, 88 (1953).
Gorbman, A.: Degenerative and regenerative changes in the thyroid gland following high dosages of radioactive iodine. Trans. New York Acad. Sci. 11, 201 (1949).
Gorbman, A.: Functional and structural changes consequent to high dosages of radioactive iodine. J. Clin. Endocrin. 10, 1177 (1950).
Gorbman, A.: and H. M. EVANS: Beginning of function in the thyroid of the fetal rat. Endocrinologv (Springfield, 111.) 32, 113 (1943).
Gordon, A. H., J. Gross, D. O’connor and R. Pitt-Rivers: Nature of the circulating thyroid hormone-plasma protein complex. Nature (London) 169, 19 (1952).
Gordon, E. S., and E. C. Albright: Treatment of thyrotoxicosis with radioactive iodine. J. Amer. Med. Assoc. 143, 1129 (1950).
Green, G. F., J. F. Tait and R. Worsnop: Some observations and problems of treatment with radioactive iodine (I131). Brit. J. Radiol. 24, 148 (1951).
Green, W. W., W. E. White, E. P. Engelmann and A. Krupp: Effect of butazolidin on I131 uptake by the thyroid gland. Proc. Soc. Exper. Biol. a. Med. 82, 155 (1953).
Greer, M. A.: Correlation of the 24-hour radioiodine uptake of the human thyroid gland with the 6-and 8-hour uptakes and the “accumulation gradient”. J. Clin. Invest. 30, 301 (1951).
Greer, M. A., and G. E. Smith: Method for increasing accuracy of I131 uptake as test for thyroid function by use of dessicated thyroid. J. Clin. Endocrin. 14, 1374 (1954).
Gros, H.: Untersuchungen über den Wirkungsmechanismus des Butazolidins. Klin. Wschr. 1956, 481.
Gross, J., and R. Pitt-Rivers: Unidentified iodine compounds in human in addition to thyroxine and iodine. Lancet 1951II, 766.
Gross, J., and R. Pitt-Rivers: Experimental study of thyroid metabolism with radioactive iodine. Brit. Med. Bull. 136, 8 (1952).
Gross, J., and R. Pitt-Rivers: The identification of 3, 5, 3M-triiodothyronine in human plasma. Lancet 1952 I, 439.
Guinet, P., Et M. Berger: L’épreuve à la thyréostimuline dans le diagnostic étio-pathogénique du myxoedème. Ann. d’Endocrin. 12, 585 (1951).
Haines, S. F., F. R. Keating, M. H. Power, M. M. D. Williams and M. P. Kelsey: The use of radioiodine in the treatment of exophthalmic goiter. J. Clin. Endocrin. 8, 813 (1948).
Hamilton, C. F., A. Albert and H. S. F. Powter: The behavior of labeled iodocasein in human myxedema. J. Clin. Endocrin. 9, 828 (1949).
Hamilton, H. B., and S. C. Werner: Effect of sodium-iodide, propylthiouracil and methyl-mercaptoimidazol during radioiodine therapy of hyperthyroidism. J. Clin. Endocrin. 11, 763 (1951).
Hamilton, H. B., and S. C. Werner: The effects of sodium iodide, 6-propylthiouracil, and l-methyl-2-mercaptoimidazole during radioiodine therapy of hyperthyroidism. J. Clin. Endocrin. 12, 1083 (1952).
Hamilton, J. G.: The rates of absorption of the radioactive isotopes of sodium, potassium, chlorine, bromine and iodine in normal human subjects. Amer. J. Physiol. 124, 667 (1938).
Hamilton, J. G.: The use of radioactive tracers in biology and medicine. Radiology 39, 341 (1942).
Hamilton, J. G., C. W. Asling, W. M. Garrison and K. G. Scott: The accumulation, metabolism and biological effects of astatine in rats and monkevs. Univ. California (Berkeley) Publ. Pharmacol. 2, 283 (1953).
Hamilton, J. G., and J. H. Lawrence: Recent clinical developments in the therapeutic application of radio-phosphorus and radioiodine. J. Clin. Invest. 21, 624 (1942).
Hamilton, J. G., M. Parrott and P. Wallace-Durbin: The accumulation and destructive action of Astatine211 (eka-iodine) in the thyroid gland of rats and monkeys. J. Clin. Endocrin. 14, 1161 (1954).
Hamilton, J. G., and M. H. Soley: A comparison of the metabolism of iodine and element 85 (eka-iodine). Proc. Nat, Acad. Sci. 26, 483 (1940).
Hamilton, J. G., and K. B. Eichorn: Deposition of radioactive iodine in human thyroid tissue. Univ. California (Berkeley) Publ. Pharmacol. 1, 339 (1940).
Hamilton, J. G., P. Wallace-Durbin and M. W. Parrott: Comparison of acute and chronic changes produced in rats by iodine 131 and astatine 211 at lethal levels. Preliminary clinical data on the uptake of astatine 211 in patients with thvroid disease. Proc. of Radioisotope Conf. 1, 212 (1954).
Hamolsky, M. W., A. S. Freedberg, G. S. Kurland and L. Wolsky: The exchangeable thyroid hormonal pool. I. Its magnitude and rate of turnover in various thyroid states in man. J. Clin. Invest. 32, 453 (1953).
Hanbury, E. M., J. Heslin, L. G. Stang, W. D. Tucker and J. E. Rall: The diagnostic use of J18?. J. Clin. Endocrin. 14, 1530 (1954).
Hanngren, Ä.: Determination of the antithyroid action of para-amino-salicylic acid using radioactive iodine. Lancet 1952 II, 117.
Harbers, E., U. P. Doering: Dosisfragen und Strahlenschädigungen bei Anwendung von Radioisotopen. Klin. Wschr. 1955, 777.
Harington, C. R.: Chemistry of thvroxine. II. Isolation of thyroxine from the thvroid gland. Biochemic. J. 20, 293 (1926).
Harington, C. R., and G. Barger: Chemistry of thyroxine. III. Constitution and synthesis of thyroxine. Biochemic. J. 21, 169 (1927).
Harper, E. O., and P. A. Mattis: Federat, Proc. 10, 306 (1951); zit. bei W. HORST U. F. KUHLENCORDT (1954).
Harsha, W. X.: Plasma protein-bound iodine determinations. Amer. J. Med. Sci. 221, 626 (1951).
Harsha, W. X.: Evaluation of the conversion of radioactive inorganic iodine to protein-bound iodine as a diagnostic aid in thyroid dysfunction. J. Clin. Endocrin. 11, 1524 (1951).
Heidelberger, M., and W. W. Palmer: The preparation and properties of thvroglobulin. J. of Biol. Chem. 101, 433 (1933).
Heidelberger, M., and K. O. Pedersen: Molecular weight and isoelectric point of the thvroglobulin. J. Gen. Physiol. 12, 95 (1935).
Hertz, S., and A. Roberts: Application of radioactive iodine in therapv of Graves disease. J. Clin. Invest, 21, 624 (1942).
Hertz, S., and R. D. Evans: Radioactive iodine as an indicator in the studv of thyroid physiology. Proc. Soc. Exper. Biol, a, Med. 38, 510 (1938).
Herve, A., J. Closon Et J. Govaerts: Cancers thyroidiens et radio-iode. J. beige Radiol. 33, 216 (1950).
Hill, S. R., R. S. Reiss, P. H. Forsham and S. W. Thorn: The effect of adrenocortico-tropin and cortisone on thyroid function: Thyroid-adrenocortical interrelationships. J. Clin. Endocrin. 10, 1375 (1950).
Himsworth, H. P., M. E. Morgans and W. R. Trotter: Thyroidectomy and thiouracil in toxic goiter; interim comparison. Lancet 1947 I, 241.
Hlad, Ch. J., and N. S. Bricker: Renal function and I131 clearance in hyperthyroidism and myxedema. J. Clin. Endocrin. 14, 1539 (1954).
Hofmann-Credner, D.: Experimentelle Untersuchungen zur Jodaufnahme durch die Haut und Lunge beim Menschen. Arch, internat. Pharmacodynamic 97, 363 (1954).
Hofmann-Credner, D., U. H. Spitzy: Zur Frage der perkutanen und respiratorischen Jodaufnahme. Arch, physik. Ther. 6, 171 (1954).
Honour, A. J., N. B. Myant and E. N. Rowlands: Secretion of radioiodine in digestive juices and milk in man. Clin. Sci. 11, 447 (1952).
Horst, W.: Zur diagnostischen Anwendung von Radiojod 131. Strahlenther. 85, 183 (1951).
Horst, W.: Die Strahlentherapie der Schilddrüsenüberfunktion mit Radiojod 131. Dtsch. med. Wschr. 1951, 1052.
Horst, W.: Methoden und Ergebnisse des Radiojodstoffwechsel-Studiums zur Diagnostik thyreoidaler und extrathyreoidaler Erkrankungen. Klin. Wschr. 1952, 439.
Horst, W.: Neue Ergebnisse der Anwendung von J131 in Diagnostik und Therapie von Schilddrüsenerkrankungen. Strahlenther. 94, 169 (1954).
Horst, W.: Indikationen und Behandlungserfolge der J131-Strahlentherapie von Schilddrüsen-erkrankungen unter Einbeziehung von Kreislauferkrankungen. Regensb. Jb. ärztl. Fortbild. 6, (1956).
Horst, W., U. E. Gadermann: Ergebnisse der Strahlenresektion bzw. Elimination der Schilddrüse mit Radiojod bei fortgeschrittenen Herzerkrankungen. Strahlenther. 97, 87 (1955).
Horst, W., U. F. Kuhlencordt: Ergebnisse der Strahlentherapie mit Radiojod (J131). Dtsch. med. Wschr. 1954, 399.
Horst, W., U. H. Rösler: Der Transport des Hormonjods in menschlichem Serum untersucht mit Papierelektrophorese und Radiojod. Zugleich ein Beitrag zur Frage der Existenz von sog. Zwischen-Fraktionen. Klin. Wschr. 1953, 13.
Houssay, A. B.: Acción de la adrenocorticotrofina y de la cortisona sobre la función tiroidea. Rev. Asoc. med. argent. 66, 132 (1952).
Huguenin, R., M. Ttjbiana, J. Abbatucci Et J. Dutreix: Méthodes de diagnostic et de sélection des cancers thyroidiens susceptibles d’être traités par l’iode radioactif. Bull. Assoc. franç. Étude Cane. 41, 322 (1954).
Ingbar, S. H.: A new method for the study of thyroidal function in man, using radioactive iodine. J. Clin. Invest. 32, 577 (1953).
Ingbar, S. H.: Simultaneous measurement of the iodide concentrating and protein-binding capacities of the normal and hyperfunctioning human thyroid gland. J. Clin. Endocrin. 15, 238 (1955).
Ingbar, S. H., and B. F. Chandler: Influence of cortisone and desoxycorticosterone upon the renal and thyroidal metabolism of iodine. J. Clin. Endocrin. 13, 853 (1953).
Ingbar, S. H., and N. Freinkel: The effect of cortisone and hydrocortisone on the peripheral utilization of thyroid hormone. J. Clin. Invest. 33, 945 (1954).
Ingbar, S. H., P. D. Hoeprich and J. W. Athens: The concentration and significance of the butanol-extractable I131 of serum in patients with diverse states of thyroidal function. J. Clin. Invest. 33, 388 (1954).
Ingbar, S. H., P. D. Hoeprich and J. W. Athens: Simultaneous estimation of rates of thyroxine degradation and thyroid hormone synthesis. J. Clin. Invest. 24, 808 (1955).
Iversen, K.: Late results from continuous treatment of thyrotoxicosis with M. T. U.; Late results. J. Clin. Endocrin. 11, 298 (1951).
Jaffe, H. L., and R. E. Ottoman: Evaluation of radioiodine test for thyroid function. J. Amer. Med. Assoc. 143, 515 (1950).
Jaffe, H. L., M. H. Rosenfeld, F. W. Pobirs and L. J. Stuppy: Treatment of advanced heart disease. Endresults in one hundred patients. J. Amer. Med. Assoc. 151, 716 (1953).
Jagic, N. V., U. O. V. Zimmermann-Meinzingen: Totale Thyreoidektomie bei Herz-und Kreislauf-Kranken. Münch, med. Wschr. 1939, 245.
Johnson, P. C., and W. H. Beierwaltes: The urinary and fecal excretion of I131 from labeled sodium-1-thyroxine in various thvroid states and in euthyroids with bile fistulas. J. Labor, a. Clin. Med. 41, 676 (1953).
Johnston, M. A. W., A. H. Squires and R. F. Farquharson: The effect of prolonged administration of thyroid. Ann. Int. Med. 35, 1008 (1951).
Judd, E. S.: The role of the surgeon in thyrotoxicosis. Surg. Clin. N. Amer. 32, 981 (1952)
Kaae, S.: The treatment of thyroid carcinoma with radioactive iodine. Acta radiol. (Stockh.) 33, 539 (1951).
Kaae, S., and O. Petersen: The treatment of thyroid carcinoma with radioactive iodine. Acta radiol. (Stockh.) 33, 539 (1950).
Keating, F., and A. Albert: The metabolism of iodine in man as disclosed with the use of radioiodine. Ree. Progr. in Hormone Res. 4, 429 (1949).
Keating, F., and A. Albert: Distribution and metabolism of radioactive 1-triiodothyronine compared with radioactive 1-thyroxine in the rat. J. Clin. Invest. 32, 580 (1953).
Keating, F., S. F. Haines, M. H. Power and M. M. D. Williams: The radioiodine-accumulating function of the human thyroid gland as a diagnostic test in clinical medicine. J. Clin. Endocrin. 10, 1425 (1950).
Keating, F., M. H. Power, J. Berkson and S. F. Haines: The urinary excretion of radioiodine in various thyroid states. J. Clin. Invest. 26, 1138 (1947).
Keating, F., R. W. Rawson, W. Peacock and R. D. Evans: The collection and loss of radioactive iodine compared with the anatomic changes induced in the thyroid of the duck by the injection of thyreotropic hormone. Endocrinology (Springfield, 111.) 36, 137 (1945).
Keating, F., J. C. Wang, Th. J. Luellen, M. M. D. Williams, M. H. Powder and W. M. Mcconahey: The measurement of the iodine-accumulating function of the human thvroid gland. J. Clin. Invest. 28, 217 (1949).
Kelly, F. J.: Observations on the calculation of thyroid weight, using empirical formulae. J. Clin. Endocrin. 14, 326 (1954).
Kelsey, M. P., S. F. Haines and F. R. Keating: Radioiodine in the study and treatment of thyroid disease. A review. J. Clin. Endocrin. 9, 171 (1949).
Kendall, E. C.: The isolation on crystalline form of the compound containing iodine which occurs in the thyroid; its chemical nature and phvsiological activity. Trans. Assoc. Amer. Physicians 30, 420 (1915).
Keston, A. S., R. P. Ball, V. K. Frantz and W. W. Palmer: Storage of radioactive iodine in a metastasis from thyroid carcinoma. Science (Lancaster, Pa.) 95, 362 (1942).
Kirkland, R. H.: Impaired organic binding of radioiodine by the thyroid following radio-iodine treatment of hyperthyroidism. J. Clin. Endocrin. 14, 565 (1954).
Klein, E.: Verschiedene Zustandsformen der Schilddrüsenhormone im Blut. Acta endocrinol. (Copenh.) 18, 22 (1955).
Kohl, D., G. Moore and S. Chou: A scintillation counter for clinical use. Nucleonics 9, 68 (1951).
Koneff, A. A., C. W. Nichols, J. Wolff and I. L. Chaikoff: The fetal bovine thyroid: Morphogenesis as related to iodine accumulation. Endocrinologv (Springfield, 111.) 45. 242 (1949).
Kreutzer, F. L., E. R. Miller, M. H. Soley and S. Lindsay: Histologie localization of absorbed radioactive iodine in some human thyroid diseases. Arch. Surg. 60, 707 (1950).
Kriss, P.: Uptake of radioactive iodine, I131, by the thyroid gland after administration of tracer doses. J. Clin. Endocrin. 10, 812 (1950).
Kühne, P., U. H. Billion: Die Altersregression der Schilddrüsenfunktion im Radiojodtest. Ärztl. Wschr. 1955, 62.
Kühl, W. J., and M. Ziff: Alternation of thyroid function by ACTH and Cortisone. J. Clin. Endocrin. 12, 554 (1952).
Kurland, G. S., D. L. Chamovitz and A. S. Freedberg: The distribution and the pathologie effects of I131 in man. J. Clin. Invest. 29, 829 (1950).
Kurland, G. S., and A. S. Freedberg: The distribution of I131 in tissue obtained at necropsy or at surgical operation in man. J. Clin. Endocrin. 11, 843 (1951).
Kurland, G. S., and J. Fishman: Effect of thyrotropin on changes in thyroid function following administration of I131 to euthyroid cardiac patients. J. Clin. Endocrin. 14, 572 ( 1954;
Lamberg, B. A.: Acta med. scand. (Stockh.) 148, 225 (1954); zit. bei H. SAUTER (1956).
Larson, F. C., W. P. Deiss and E. C. Albright: Localization of protein bound radioactive iodine by filter paper electrophoresis. Science (Lancaster, Pa.) 115, 626 (1952).
Larsson, L. G.: Acta radiol. (Stockh.) Suppl. 126, 38 (1955); zit. bei H. BRÜGEL (1956).
Larsson, L. G., and J. Ragnhult: A study of the iodine-concentrating function of the thyroid after treatment with radioactive iodine. Acta radiol. (Stockh.) 39, 477 (1952).
Leblond, C. P., M. B. Fertman, I. D. Puppel and G. M. Curtis: Radioiodine autography in studies of human goitrous thyroid glands. Arch, of Path. 41, 510 (1946).
Larsson, L. G., and J. Gross: The mechanism of the secretion of thyroid hormone. J. Clin. Endocrin. 9, 149 (1949).
Larsson, L. G., and W. Mann: Function of iodine by the thyroid of rats given diets deficient in iodine. Proc. Soc. Exper. Biol. a. Med. 49, 102 (1942).
Larsson, L. G., Et J. Sue: Passage de l’iode radioactif (J128) dans la thyroide stimulée par l’hormone thyreotrope de l’hypophyse. C. r. Soc. Biol. (Paris) 133, 543 (1940).
Leblond, C. P., J. Sue: Iodine fixation in the thyroid as influenced by hypophysis and other factors. Amer. J. Physiol. 134, 549 (1941).
Leiter, L., S. M. Scidlin, L. D. Marinelli and E. J. Baumann: The effect of thiouracil on hyperthyroidism and on the uptake of radioactive iodine in patients with adeno-carcinoma of the thyroid and functioning metastases. J. Clin. Invest. 23, 941 (1944).
Leiter, L., S. M. Scidlin, L. D. Marinelli and E. J. Baumann: Adenocarcinoma of the thyroid with hyperthyroidism and functioning metastases. I. Studies with thiouracil and radio-iodine. J. Clin. Endocrin. 6, 247 (1946).
Letton, A. H., and J. P. Wilson: Cancer of the thyroid. J. Internat. Coll. Surg., Chicago 24, 79 (1955).
Levy, R. P., L. W. Kelly and W. M. Jefferies: The study of thyroid function by means of a single injection of thyrotropin. J. Clin. Invest. 32, 583 (1953).
Levy, R. P., L. W. Kelly and W. M. Jefferies: The relationship between changes in thyroidal I131 uptake and serum protein-bound iodine following thyrotropin. J. Clin. Invest. 33, 953 (1954).
Lewis, J. W.: Simplified method for determining thyroid function with radioiodine. Nucleonics 12, 59 (1954).
Lindeboom, G. A., T. E. Hoogendijk Van Dort and J. De Jong: Blood levels of I131 after tracer doses in patients with thyrotoxicosis with radioiodine. Acta med. scand. (Stockh.) 150, 487 (1955).
Linder, F., U. F. Ruf: Schilddrüsen-Carcinom und Radiojod. Künstliche Radioaktive Isotope in Physiologie, Diagnostik und Therapie. Berlin-Göttingen-Heidelberg: Springer-Verlag 1953.
Loeser, A.: Über endokrine Jodwirkungen, ihre Streuung und medikamentöse Beeinflussung. Dtsch. med. Wschr. 1950, 36.
Luellen, T. J., F. R. Keating, M. M. D. Williams, J. Bergson, M. J. Power and W. M. Mcconahey: Relative measurement in vivo of accumulation of radioiodine by the human thyroid gland: Comparison with radioactivity in peripheral tissues. J. Clin. Invest. 28, 207 (1948).
Macgregor, A. G.: Radioactive iodine in the diagnosis of thyrotoxicosis. Brit. J. Radiol. 23, 550 (1950).
Macintyre, W. J.: A scintillation counter for measurement of I131 uptake in the thyroid gland. Proc. Soc. Exper. Biol. a. Med. 75, 561 (1950).
Mack, R. E.: The use of radioactive iodine in the diagnosis and treatment of hyperthyroidism. Missouri Med. 50, 267 (1953).
Maloof, F., and E. M. Chapman: Responses to radioactive iodine therapy in hyperthyroidism, with special reference to cardiac problems. J. Clin. Endocrin. 11, 1296 (1951).
Maloof, F., B. M. Dobyns and S. L. Vickery: The effects of various doses of radioactive iodine on the function and structure of the thyroid of the rat. Endocrinology (Springfield, 111.) 50, 612 (1952).
Mandl, F., U. E. Singer: Thyreoidektomie bei Herzkranken. Wien. klin. Wschr. 1936 II, 1355.
Marine, D., and A. Johnson: Experimental observations on the effects of the administration of iodine in three cases of thyroid carcinoma. Arch. Int. Med. 2, 228 (1913).
Marine, D., and J. M. Rogoff: The absorption of potassium iodide by the thyroid gland in vivo, following its intravenous injection in constant amounts. J. Pharmacol. 8, 439 (1916).
Marinelli, L. D.: Dosage determination in the use of radioactive isotopes. J. Clin. Invest. 28, 1271 (1949).
Marinelli, L. D., F. W. Foote, R. F. Hill and A. Hocker: Retention of radioactive iodine in thyroid carcinomas; histopathologic and radioautographic studies. Amer. J. Roentgenol. 58, 17 (1947).
Marinelli, L. D., U. R. F. Hill: Studies on dosage in cancer therapy. Brookhaven Conf. Rep. on radio-iodine Assoc., Univ., Inc., Upton, N. Y. p. 98, 1948.
Marinelli, L. D., U. R. F. Hill: Radiation dosimetry in the treatment of functional thyroid carcinoma with I131. Radiology 55, 494 (1950).
Marinelli, L. D., E. H. Quimby and G. J. Hine: Dosage determination with radioactive isotopes. II. Practical considerations in therapy and protection. Amer. J. Roentgenol. 59, 260 (1948).
Marinoni, U., E C. Picchio: Tumori della tiroide e iodio radioattivo. Radiol, med. 40, 790 (1954).
Martin, J. M., and J. B. Stanbury: The response of the I131-treated thyroid gland to thyro-tropic hormone. J. Clin. Endocrin. 15, 811 (1955).
Martint, P.: Diagnostik und Therapie der Hyperthyreose. Dtsch. med. Wschr. 1955, 1625.
Mason, A S., and R. Olivier: Urinary excretion of radioactive iodine as a diagnostic aid in thyroid disorders. Lancet 1949 II, 456.
Maurer, W., U L. Reichenbach: Über die Bindung des organischen Jods im Serum an einzelne Serum Eiweißfraktionen. Naturwiss. 39, 261 (1952).
Mayneord, W. V., and W. K. Sinclair: A dosimetry of artificial radioactive isotopes. Adv. Biol. Med. Phys N. Y. 3, 1 (1953).
Mcarthur, J. W., R. W. Rawson, R. G. Fluharty and J. H. Means: The urinary excretion of radioactive iodine as an aid in diagnosis of hyperthyroidism. Ann. Int. Med. 29, 229 (1948).
Mcconahey, W. M., F. R. Keating and M. H. Power: An estimation of the renal and extrarenal clearance of radioiodine in man. J. Clin. Invest. 30, 778 (1951).
Mccullagh, E. P.: Radioactive iodine in the treatment of hyperthvroidism. Ann. Int. Med. 37, 739 (1952).
Mccullagh, E. P., A. Gold and J. B. R. Mckendry: Radioactive iodine uptake in the hypermetabolism of acromegaly. J. Clin. Endocrin. 10, 687 (1950).
Mccullagh, E. P., and C. E. Richards: Radioactive iodine in the treatment of hyperthvroidism. xlrch. Int. Med. 87, 4 (1951).
Mcgavack, T. H.: The current treatment of hyperthyroidism. Med. Clin. N. Amer. 37, 695 (1953).
Mcginty, D. A., and E. A. Sharp: Effect of iodine intake on thyroid iodine distribution and thyroid weight of rats treated with thiouracil and other goitrogens. J. Clin. Endocrin. 6, 473 (1946).
Meckstroth, C. V., and G. M. Curtis: Criteria for therapy of malignant thyroid lesions with I131. Arch. Surg. 67, 187 (1953).
Meissner, J., J. Kracht U. W. Diller: Nachweis der Schreckthyreotoxikose des Wild-kaninchens mit radioaktivem Jod. Arch, exper. Path. u. Pharmakol. 216, 424 (1952).
Middlesworth, L. Van: Metabolism of I131 in severe anoxia. Science (Lancaster, Pa.) 110, 120 (1949).
Middlesworth, L. Van, and M. M. Berry: Iodide metabolism during anoxia, nephrectomy, trauma, avitaminoses and starvation in the rat. Amer. J. Physiol. 167, 576 (1951).
Migeon, C. J., L. I. Gardner, J. F. Crigler and L. Wilkins: Effect of cortisone treatment for 28 days on radio-iodine metabolism in normal rats and adrenalectomized rats main-tained with desoxycorticosterone. Endocrinology (Springfield, 111.) 51, 117 (1952).
Miller, E. R., M. E. Dailey and H. J. Mccorkle: Evaluation of treatment of hyperthyroidism with radioiodine. Arch. Surg. 65, 12 (1952).
Miller, E. R., A. V. Holmes, G. L. Alexander and G. E. Sheline: Studies with radioiodine. I. Function and rate of I131 uptake of thyroid. Radiology 57, 37 (1951).
Miller, E. R., M. H. Soley, N. Foreman, A. V. Holmes, G. L. Alexander and G. E. Sheline: Studies with radioiodine. II. Treatment of patients with hyperthyroidism by I131. Radiology 57, 227 (1951).
Miller, E. R., and G. E. Sheline: Studies with radioiodine. III. Problems of dosage in the treatment of hyperthyroidism. Radiology 57, 72 (1951).
Miller, O. B., W. A. Selle and T. Gibbs: Studies in percutaneous absorption of radioiodine. J. Invest. Dermat. 12, 19 (1949).
Mitchell, J. S.: Practical aspects of radioactive isotopes in relation to medical treatment. Brit. Med. J. 1951, No. 4734, 747.
Moe, R. H., E. E. Adams, J. H. Rule, M. C. Moore, J. E. Kearns and D. E. Clark: An evaluation of radioactive iodine in the treatment of hyperthyroidism. J. Clin. Endocrin. 10, 1022 (1950).
Money, W. L., P. J. Fitzgerald, J. T. Godwin and R. W. Rawson: The effect of thiouracil on the collection of radioactive iodine in experimentally induced thyroid tumors. Cancer (N. Y.) 6, 11 (1953).
Money, W. L., J. E. Rall and R. W. Rawson: The effect of low iodine diet on thyroid function in rat. J. Clin. Endocrin. 12, 1495 (1952).
Morgans, M. F., A. K. Oldham and W. R. Trotter: The effect of exogenous thyroxine on radioiodine uptake in normal subjects and in cases of thyrotoxicosis in remission. J. of Endocrin. 8, 250 (1952).
Morgans, M. E., and W. R. Trotter: Treatment of thyrotoxicosis with potassium Perchlorate. Lancet 1954 I, 749.
Morris, H. P.: The experimental development and metabolism of thyroid gland tumors. Adv. Cancer Res. 3, 51–115 (1955), Acad. Press. Inc. Publishers.
Morton, M. E., I. L. Chaikoff and S. Rosenfeld: Inhibiting effect of inorganic iodide on the formation in vitro of tissue with radioactive iodine as indicator. J. of Biol. Chem. 147, 1 (1943).
Morton, M. E., I. Perlman, E. Anderson and I. L. Chaikoff: Radioactive iodine as an indicator of the metabolism of iodine. V. The effects of hypophysectomy on the distribution of labeled thyroxine and diiodotyrosine in thyroid gland and plasma. Endocrinologv (Spring-field, 111.) 30, 495 (1942).
Muller, H. J.: Gene mutations caused bv radiation. Symposium on Radiobiolgy (N. Y. ) 1952, 296–332.
Müller, J. H., U. H. Aeppli: Über die Verwendung von Radiojod (J131) als Indikator der Schilddrüsenfunktion nach Einwirkung von Gonadotropin, männlichen und weiblichen Sexualhormonen. Experientia (Basel) o, 297 (1949).
Mueller, R., C. C. Brausch, E. Z. Hirsch, R. S. Benua and B. M. Dobyns: Uptake of radioactive iodine in the thyroid of patients with impaired liver function. J. Clin. Endocrin. 14, 1287 (1954).
Muylder, E. De, Et J. Maisin: Valeur comparative du métabolisme de base de l’excrétion urinaire d’iode marqué comme test de la fonction thyroidienne. Ann. d’Endocrin. 12, 1098 (1951).
Myant, N. B.: Prognostic value of early tests of thyroid function after treatment of thyrotoxicosis by I131. Brit. J. Radiol. 26, 139 (1953).
Myant, N. B., B. D. Corbett, A. J. Honour and E. E. Pochin: Distribution of radioiodide in man. Clin. Sci. 9, 405 (1950).
Myant, N. B., A. J. Honour and E. E. Pochin: Estimation of radioiodine in the thyroid gland of living subjects. Clin. Sci. 8, 135 (1949).
Myant, N. B., and E. E. Pochin: The thyroid clearance rate of plasma iodine and a measure of thyroid activity. Proc. Roy. Soc. Med. 42, 959 (1949).
Myant, N. B.: The metabolism of radiothyroxine in man. Clin. Sci. 9, 421 (1950).
Myant, N. B., and E. A. G. Goldie: The plasma iodide clearance rate of the human thyroid. Clin. Sci. 8, 109 (1949).
Nelson, N., E. D. Palmes, C. R. Park, P. P. Weymouth and W. B. Bean: The absorption, excretion, and physiological effect of iodine in normal human subjects. J. Clin. Invest. 26, 301 (1947).
Nicholson, J. P., C. W. Wilson and K. A. Newton: The distribution of radioiodine observed in thyroid disease by means of GEIGER counters-Its determination and significance. Amer. J. Roentgenol. 72, 849 (1954).
Nicholson, J. P., and R. G. C. Maclaren: The use of radioiodine in the study of thyroid disorders. Radiology 64, 567 (1955).
Nodine, J. H., W. H. Perloff, D. De Albuquergue, L. Perczek and B. Channick: The diphasic character of thyreoidal I131 clearance. J. Clin. Endocrin. 15, 347 (1955).
Oberdisse, K.: Die Behandlung der Hyperthyreosen mit antithyreoidalen Substanzen. Dtsch. med. Wschr. 1956, 506.
Oddie, T. H., I. Meschen and J. T. Wortham: Thyroid function assay with radioiodine III. Clinical test results and diagnostic limits for rate constants. J. Clin. Invest. 24, 1044 (1955).
Oddie, T. H., and R. K. Scott: External measurement of radio-iodine in the thyroid gland. Brit. J. Radiol. 22, 698 (1949).
Oddie, T. H., and R. K. Scott: Results of uptake and excretion test with radio-iodine. Brit. J. Radiol. 23, 349 (1950).
Odenthal, F.: Die Behandlung der Thyreotoxikose mit radioaktivem Jod. Dtsch. med. Wschr. 1954, 1568.
Oeff, K., K. Kreutz U. M. Kessel: J131-Clearance der normalen und pathologischen Magen-schleimhaut. Klin. Wschr. 1955, 59.
Oeser, H., H. Billion U. H. G. Mehl: Die Behandlung der Hyperthyreosen mit Radiojod. Künstliche Radioaktive Isotope in Physiologie, Diagnostik und Therapie. S. 798–825. Berlin-Göttingen-Heidelberg: Springer-Verlag 1953.
Oliver, R.: Use of a scintillation gamma counter for the estimation of iodine 131 in liquid samples. Brit. J. Radiol. 26, 663 (1953).
Owen, C. A., and M. H. Power: Distribution of iodide between cells and plasma as measured by means of radioactive iodide. J. of Biol. Chem. 200, 111 (1953).
Papper, S., B. A. Burrows, S. H. Ingbar, J. H. Sisson and J. F. Ross: The effects of 1-thyroxine sodium on nontoxic goiter, on myxedema and on the thyroid uptake of radioactive iodine. New England J. Med. 247, 897 (1952).
Paschkis, K. E., A. Cantarow, E. Eberhard and D. Boyle: Thyroid function in the alarm reaction. Proc. Soc. Exper. Biol. a. Med. 73, 116 (1950).
Paterson, R.: The treatment of thyroid carcinoma by radioiodine. Brit. J. Radiol. 23, 553 (1950).
Perinetti, H., E. B. Del Castillo, J. E. Itoiz, J. B. Stanbury, G. L. Brownell, D. S. Riggs, E. Trucco, A. Houssay Y A. G. Yaciofano: La glandula tiroidea humana déficiente en yodo. Medicina (Buenos Aires) 12, 17 (1952).
Perlmutter, M., and D. S. Riggs: Thyroid collection of radioactive iodide and serum protein-bound iodine concentration in senescence, in hyperthyroidism and hypo-pituitarism. J. Clin. Endocrin. 9, 430 (1949).
Perlmutter, M., S. Weisenfeld, S. Slater, E. Wallace and M. M. David: A study of the mechanism of the inhibition of the thyroid gland induced by ingestion of thyroid substance. J. Clin. Endocrin. 12, 208 (1952). Ergebnisse d. inn. Medizin, N. F. Bd. 8 17
Müller, J. H., U. H. Aeppli: Über die Verwendung von Radiojod (J131) als Indikator der Schilddrüsenfunktion nach Einwirkung von Gonadotropin, männlichen und weiblichen Sexualhormonen. Experientia (Basel) o, 297 (1949).
Mueller, R., C. C. Brausch, E. Z. Hirsch, R. S. Benua and B. M. Dobyns: Uptake of radioactive iodine in the thyroid of patients with impaired liver function. J. Clin. Endocrin. 14, 1287 (1954).
Muylder, E. De, Et J. Maisin: Valeur comparative du métabolisme de base de l’excrétion urinaire d’iode marqué comme test de la fonction thyroidienne. Ann. d’Endocrin. 12, 1098 (1951).
Myant, N. B.: Prognostic value of early tests of thyroid function after treatment of thyrotoxicosis by I131. Brit. J. Radiol. 26, 139 (1953).
Myant, N. B., B. D. Corbett, A. J. Honour and E. E. Pochin: Distribution of radioiodide in man. Clin. Sci. 9, 405 (1950).
Myant, N. B., A. J. Honour and E. E. Pochin: Estimation of radioiodine in the thyroid gland of living subjects. Clin. Sci. 8, 135 (1949).
Myant, N. B., and E. E. Pochin: The thyroid clearance rate of plasma iodine and a measure of thyroid activity. Proc. Roy. Soc. Med. 42, 959 (1949).
Myant, N. B:., The Metabolism Of Radiothyroxine In Man. Clin. Sci. 9, 421 (1950).
Myant, N. B., and E. A. G. Goldie: The plasma iodide clearance rate of the human thyroid. Clin. Sci. 8, 109 (1949).
Nelson, N., E. D. Palmes, C. R. Park, P. P. Weymouth and W. B. Bean: The absorption, excretion, and physiological effect of iodine in normal human subjects. J. Clin. Invest. 26, 301 (1947).
Nicholson, J. P., C. W. Wilson and K. A. Newton: The distribution of radioiodine observed in thyroid disease by means of GEIGER counters-Its determination and significance. Amer. J. Roentgenol. 72, 849 (1954).
Nicholson, J. P., and R. G. C. Maclaren: The use of radioiodine in the study of thyroid disorders. Radiology 64, 567 (1955).
Nodine, J. H., W. H. Perloff, D. De Albuquergue, L. Perczek and B. Channick: The diphasic character of thyreoidal I131 clearance. J. Clin. Endocrin. 15, 347 (1955).
Oberdisse, K.: Die Behandlung der Hyperthyreosen mit antithyreoidalen Substanzen. Dtsch. med. Wschr. 1956, 506.
Oddie, T. H., I. Meschen and J. T. Wortham: Thyroid function assay with radioiodine III. Clinical test results and diagnostic limits for rate constants. J. Clin. Invest. 24, 1044 (1955).
Oddie, T. H., and R. K. Scott: External measurement of radio-iodine in the thyroid gland. Brit. J. Radiol. 22, 698 (1949).
Oddie, T. H., and R. K. Scott: Results of uptake and excretion test with radio-iodine. Brit. J. Radiol. 23, 349 (1950).
Odenthal, F.: Die Behandlung der Thyreotoxikose mit radioaktivem Jod. Dtsch. med. Wschr. 1954, 1568.
Oeff, K., K. Kreutz U. M. Kessel: J131-Clearance der normalen und pathologischen Magen-schleimhaut. Klin. Wschr. 1955, 59.
Oeser, H., H. Billion U. H. G. Mehl: Die Behandlung der Hyperthyreosen mit Radiojod. Künstliche Radioaktive Isotope in Physiologie, Diagnostik und Therapie. S. 798–825. Berlin-Göttingen-Heidelberg: Springer-Verlag 1953.
Oliver, R.: Use of a scintillation gamma counter for the estimation of iodine 131 in liquid samples. Brit. J. Radiol. 26, 663 (1953).
Owen, C. A., and M. H. Power: Distribution of iodide between cells and plasma as measured by means of radioactive iodide. J. of Biol. Chem. 200, 111 (1953).
Papper, S., B. A. Burrows, S. H. Ingbar, J. H. Sisson and J. F. Ross: The effects of 1-thyroxine sodium on nontoxic goiter, on myxedema and on the thyroid uptake of radioactive iodine. New England J. Med. 247, 897 (1952).
Paschkis, K. E., A. Cantarow, E. Eberhard and D. Boyle: Thyroid function in the alarm reaction. Proc. Soc. Exper. Biol. a. Med. 73, 116 (1950).
Paterson, R.: The treatment of thyroid carcinoma by radioiodine. Brit. J. Radiol. 23, 553 (1950).
Perinetti, H., E. B. Del Castillo, J. E. Itoiz, J. B. Stanbury, G. L. Brownell, D. S. Riggs, E. Trucco, A. Houssay Y A. G. Yaciofano: La glandula tiroidea humana déficiente en yodo. Medicina (Buenos Aires) 12, 17 (1952).
Perlmutter, M., and D. S. Riggs: Thyroid collection of radioactive iodide and serum protein-bound iodine concentration in senescence, in hyperthyroidism and hypo-pituitarism. J. Clin. Endocrin. 9, 430 (1949).
Perlmutter, M., S. Weisenfeld, S. Slater, E. Wallace and M. M. David: A study of the mechanism of the inhibition of the thyroid gland induced by ingestion of thyroid substance. J. Clin. Endocrin. 12, 208 (1952). Ergebnisse d. inn. Medizin, N. F. Bd. 8 17
Rawson, R. W., J. E. Rall and W. Peacock: Limitations and indications in the treatment of cancer of the thyroid with radioactive iodine. J. Clin. Endocrin. 11, 1128 (1951).
Rawson, R. W., and J. Robbins: Uses and misuses of radioactive iodine in treatment of cancer of thyroid. Arch. Int. Med. 92, 299 (1953).
Rawson, R. W., B. N. Skanse, L. D. Marinelli and R. G. Fluharty: Radioactive iodine, its use in studying certain functions of normal and neoplastic thyroid tissues. Cancer (N. Y.) 2, 279 (1949).
Rawson, R. W., and J. Trunnell: Radioactive iodine in the study and treatment of carcinoma of the thyroid. (A manual of artifical radioisotope therapy, Chapter VII. New York: Academic Press., Inc. N. Y. 1951.
Redon, H., M. Tubiana, J. Abbatucci Et Fortier: Exploration thyrodienne par forage biopsique (drilling-ponction), mesures de radioactivité et autoradiographie des fragments prélevés. Ann. d’Endocrin. 14, 450 (1953).
Reid, Q. F., and J. A. Sorenson: Effective thyroid depth and compensating measurements for iodine uptake determination. Radiology 58, 390 (1952).
Reiss, M., C. P. Haigh, R. E. Hemphill, R. Maggs, J. M. Reiss and S. Smith: Studies of the human thyroid function, measured by radioiodine, and its relation to the basal metabolic rate. J. of Endocrin. 8, 1 (1952).
Reynolds, L., K. E. Corrigan and H. S. Hayden: Diagnostic use of radioactive isotopes. Amer. J. Roentgenol. 68, 421 (1952).
Richards, C. E. S G. Crile and E. P. Mccullagh: Radioactive iodine in the treatment of the hyperthyroidism of nodular goiter. J. Clin. Endocrin. 10, 1077 (1950).
Riggs, D. S., E. B. Man and Winkler: Serumjodide of euthyroid subjects treated with disseccated thyroid. J. Clin. Invest. 24, 722 (1945).
Rigler, R. G., and P. W. Scanton: Radiation parotitis from radioactive iodine therapv. Proc. Staff Meet. Mayo Clin. 30, 149 (1955).
Ritter, K., G. Bornmann U. A. Loeser: Allgemeinstoffwechsel und Trijodthyronin. Klin. Wschr. 1955, 743.
Robbins, J., and J. E. Rall: Zone electrophoresis in filter paper of serum I131 after radio-iodide administration. Proc. Soc. Exper. Biol. a. Med. 81, 530 (1952).
Robertis, E. De: Cytological and cytochemical bases of thyroid function. Ann. N. Y. Acad. Sci. 50, 317 (1949).
Robertson, J. S., and J. T. Godwin: Calculation of radioactive iodine beta radiation dose to the bone marrow. Brit. J. Radiol. 27, 241 (1954).
Roche, J., S. Lissitzky Et R. Michel: Sur la triiodothyronine, produit intermédiaire de la transformation de la diiodothyronine en thyroxine. C. r. Acad. Sci. (Paris) 234, 997 (1952).
Rotblat, J., and G. M. Owen: The biological half-life of I131 in thyroid carcinoma. Proc. Radioisotope Conf. 1, 68 (1954).
Ruedemann, A. D., and K. E. Corrigan: Glandular type exophthalmos methods of treatment, including radioactive iodine. Trans. Amer. Ophthalm. Soc. 51, 333 (1954).
Ruegamer, W. R.: The kinetics of I131 metabolism in the dog and human. Arch, of Biochem. 47, 119 (1953).
Rugh, R., and E. Booth: Modification of maternal and fetal effects of radioiodine by pre-treatment of the mother. J. of Pediatr. 44, 516 (1954).
Salter, W. T., M. De Visscher, G. B. Mcadams and I. Rosenblum: Changes in blood iodine fractions and radioactivity under therapy. J. Clin. Endocrin. 11, 1512 (1951).
Sauter, H.: Der isolierte “Basedow”-Exophthalmus. Dtsch. med. Wschr. 1950, 1614.
Sauter, H.: Weitere Erfahrungen mit der Hypophysenbestrahlung beim malignen Exophthalmus. Dtsch. med. Wschr. 1952, 1388.
Sauter, H.: Die Stellung des endokrinen Exophthalmus innerhalb des Hypophysen-Schilddrüsensystems. Dtsch. med. Wschr. 1956, 761.
Scherf, D.: Totale Thyreoidektomie bei Herzkrankheiten. Med. Klin. 1987, 1126.
Schiff, L., C. D. Stevens, W. E. Molle, H. Steinberg, C. W. Kumpe and P. Stewart: Gastric (and salivary) excretion of radioiodine in man. J. Nat. Cancer Inst. 7, 349 (1947).
Schuchter, A., U. W. Bartsch: Über die Beeinflussung der Schilddrüsenfunktion durch Tumoren im Bereich der Sella und des Zwischenhirns. Ärztl. Wschr. 1952, 939.
Schultz, A. L., and W. E. Jacobson: The effect of propylthiouracil on the thyroid uptake of I131 and the plasma conversion ratio in hyperthyroidism. J. Clin. Endocrin. 12, 1205 (1952).
Schultz, A. L., S. Sandhaus, H. L. Demorest and L. Zieve: Clinical value of the plasma butanol-extractable (Thyroxine) I131 in the diagnosis of hyperthyroidism and myxedema. Clin. Endocrin. 14, 1062 (1954).
Scott, W. G., W. B. Seaman, C. Macbryde, L. Gottlieb, W. H. Daughaday and B. J. Sweeney: Observations and results in the treatment of hyperthyroidism with radioactive iodine (I131). Amer. J. Roentgenol. 66, 171 (1951).
Searle, H. H., O. Davies and S. Lindsay: Metastatic carcinoma of thyroid gland as initial manifestation of disease. Calif. Med. 76, 62 (1952).
Seed, L., and T. Fields: Treatment of toxic goiter with radioactive iodine. Springfield, 111.: Ch. C. Thomas 1953.
Seed, L., and B. Jaffe: Results of treatment of toxic goiter with radioactive iodine. J. Clin. Endocrin. 13, 107 (1953).
Seed, L., and B. Jaffe: Comparison of the tracer dose and the therapeutic dose of I131 as to thyroid uptake, effective half life, and roentgen dosage. Radiology 63, 551 (1954).
Seidlin, S. M.: Twelve cases of metastatic carcinoma of the thyroid studied with radioactive iodine. Proc. for Study of Internal Secretion, June 6–7 (1947).
Seidlin, S. M.: Clinical methods and results of radioiodine therapy in metastatic cancer. Brookhaven Conf. Report BNL-C-5, 106 (1948).
Seidlin, S. M.: Radioiodine as a diagnostic and therapeutic tool in clinical medicine. Rec. Progr. in Hormone Res. 4, 483 (1949).
Seidlin, S. M.: Radioiodine in the treatment of metabolic thyroid carcinoma. Med. Clin. N. Amer. 1952, 663–680
Seidlin, S. M., and L. D. Marinelli: Therapeutic effect of radioactive iodine on adenocarcinoma of the thyroid with functioning metastases. Bull. N. Y. Acad. Med. 21, 440 (1945).
Seidlin, S. M., and E. Oshry: Radioactive iodine therapy: Effect on functioning metastases of adenocarcinoma of the thyroid. J. Amer. Med. Assoc. 132, 838 (1946).
Seidlin, S. M., E. Oshry, B. S. Yalow and A. A. Yalow: Spontaneous and experimentally induced uptake of radioactive iodine in metastases from thyroid carcinoma. J. Clin. Endocrin. 8, 423 (1948).
Seidlin, S. M., J. Rossman, E. Oshry and E. Siegel: Radioiodine therapy of metastases from carcinoma of the thyroid (A six year progress report). J. Clin. Endocrin. 9, 1122 (1949).
Seidlin, S. M., A. A. Yalow and E. Siegel: Irradiation produced rise in blood radioiodine concentration following ingested therapeutic dose for metastatic thyroid carcinoma. Proc. Soc. Exper. Biol. a. Med. 76, 711 (1951).
Seidlin, S. M., A. A. Yalow and E. Siegel: Blood radiation dose during radioiodine therapy of metastatic thyroid carcinoma. Radiology 63, 797 (1954).
Shapiro, M. R.: Morphologic changes in the thyroid gland following radioiodine therapy. Ann. West. Med. Surg. 4, 274 (1950).
Shellabarger, C. J., and J. T. Godwin: Studies on the thyroidal uptake of Astatine in the rat. J. Clin. Endocrin. 14, 1149 (1954).
Shipley, R. A., and F. H. Macintyre: Effect of stress, TSH and ACTH on the level of serum hormonal I131. J. Clin. Endocrin. 14, 309 (1954).
Shipley, R. A., I. P. Storaasli, H. L. Friedell and A. M. Potts: I131 in the diagnosis and treatment of hyperthyroidism. Amer. J. Roentgenol. 64, 576 (1950).
Siedek, H.: Totale Thyreoidektomie bei Herzkranken. Erg. inn. Med. 59, 1 (1940).
Silver, S., M. H. Fieber and S. B. Yohalem: Blood levels after tracer doses of radioactive iodine in the diagnosis of thyroid disorders. Amer. J. Med. 13, 725 (1952).
Skanse, B. N.: Radioactive iodine: Its use in studying the urinary excretion of iodine by humans in various states of thyroid function. Acta med. scand. 131, 251 (1948).
Skanse, B. N.: Radioactive iodine in the diagnosis of thyreoid disease. Acta med. scand. (Stockh.) 235, 1 (1949).
Soffer, L. J., J. L. Gabrilove and J. W. Jailer: Role of adrenal in uptake of I131 by thyroid following parenteral administration of epinephrine. Proc. Soc. Exper. Biol. a. Med. 71, 117 (1949).
Soliman, F. A., and E. P. Reineke: Changes in uptake of radioactive iodine by the thyroid of the rat during the estrous cycle. Amer. J. Physiol. 178, 89 (1954).
Soliman, F. A., and E. P. Reineke: Cyclic variation in thyroid function of female mice as assessed by radioactive iodine. J. of Endocrin. 10, 305 (1954).
Soley, M. H., and N. Foreman: Radioiodine therapy in Graves’ disease (A review). J. Clin. Invest, 28, 1367 (1949).
Soley, M. H., and E. R. Miller: Treatment of Graves’ disease with radioactive iodine. Med. Clin. N. Amer. 32, 3 (1948).
Soley, M. H., and N. Foreman: Graves’ disease: Treatment with radioiodine (I131). J. Clin. Endocrin. 9, 29 (1949).
Sorrentino, J., B. Roswit and R. Yalow: Thyroid carcinoma with multiple metastases and pathological fracture-successfully treated with radioiodine. Report of a case. Radiology 57, 729 (1951).
Specht, N. W., F. K. Bauer and R. M. Adams: Thyroid carcinoma. Visualization of a distant osseus metastasis by Scintiscanner, observations during I131 therapv. Amer. J. Med. 14, 766 (1953).
Stanbury, J. B., G. L. Brownell, J. Barzelatto, J. Correa, J. Maisterrena, J. Cortazar and J. Rodriguez-Soto: The metabolic fate of I131 after large therapeutic doses in patients with metastatic carcinoma of the thyroid. J. Clin. Endocrin. 12, 1480 (1952).
Stanbury, J. B., D. S. Riggs, H. Perinetti, E. Del Castillo, I. Itoiz, A. Houssay and E. Trucco: The iodine-deficient human thyroid gland. A preliminary report. J. Clin. Endocrin. 12, 191 (1952).
Stanbury, J. B., and J. B. Wyngaarden: Effect of Perchlorate on the human thyroid gland. Metabolism 1, 533 (1952).
Stang, L. G., W. D. Tucker, H. O. Banks, R. F. Doering and T. H. Mills: Production of iodine-132. Nucleonics 12, 22 (1954).
Stanley, M. M., and E. B. Astwood: Determination of the relative activities of antithyroid compounds in man using radioactive iodine. Endocrinology (Springfield, 111.) 41, 66 (1947).
Stanley, M. M., and E. B. Astwood: The accumulation of radioactive iodide by the thyroid gland in normal and thyrotoxic subjects and the effect of thiocyanate on its discharge. Endocrinology (Springfield, 111.) 42, 107 (1948).
Stanley, M. M., and E. B. Astwood: The response of the thyroid gland in normal administration of thyrotropin, as shown by studies with I131. Endocrinology (Springfield, 111.) 44, 49 (1949).
Starr, P., and R. Liebhold-Schueck: Theory of thyroid hormone action. Conclusions derived from differences in effect of sodium 1-thyroxine, sodium d-thyroxine, triijdo-thyronine and potassium iodide on uptake of radioactive iodine by thyroid gland of normal human subjects. Arch. Int. Med. 92, 880 (1953).
Starr, P., and R. W. Rawson: A graphic representation of thyroid response to stimulation by thyrotropic hormone. Proc. Soc. Exper. Biol. a. Med. 35, 603 (1937).
Starr, P., and R. Roskelley: A comparison of the effects of cold and thyrotropic hormone on the thyroid gland. Amer. J. Physiol. 130, 549 (1940).
Steinitz, K.: Fortschritte in der Diagnose und Therapie der Erkrankungen der Schilddrüse. Klin. Wschr. 1956, 265.
Sterling, K., J. C. Lashof and E. B. Man: Disappearance from serum of I131-labeled 1-thyr-oxine and 1-triiodothyronine in euthyroid subjects. J. Clin. Invest. 33, 1031 (1954).
Stirrett, R. L., D. W. Petit and P. Starr: Therapeutic studies in hyperthyroidism: Methyl-thiouracil. J. Clin. Endocrin. 12, 719 (1952).
Storaasli, J. P., S. Rosenberg and H. L. Friedell: Effect of food and water on thyroid uptake of radio-iodine (I131). Proc. Soc. Exper. Biol. a. Med. 83, 748 (1953).
Strauss, E., J. Hiller U. A. Jakob: Zur Statistik des Radiojodtestes. Verh. dtsch. Ges. Verdauungskrkh. 1954, 181.
Stump, W.: Funktionelle Störungen der Schilddrüse bei endemischer Struma, untersucht mittels radioaktiven Jods ( J131 ). Habilitationsschrift, Freiburg 1954.
Sturgeon, C. T., F. E. Davis, B. Catz, D. Petit and P. Starr: Treatment of thyroid cancer metastases with TSH and I131 during thyroid hormone medication. J. Clin. Endocrin. 13, 1391 (1953).
Sturm, A., U. W. Wernitz: Hormonjod im Gehirn. Klin. Wschr. 1956, 93.
Szilagyi, D. E., R. Mcclure, T. H. Connell, J. H. L. Wtatson and L. E. Preuss: Radio-iodine (I131) tracer studies after total thyreoidectomy. Ann. Surg. 134, 546 (1951).
Taurog, A., I. L. Chaikoff and D. D. Feller: The mechanism of iodine concentration by the thyroid gland: Its non-organic iodine-binding capacity in the normal and propyl-thiouracil-treated rat. J. of Biol. Chem. 171, 189 (1947).
Taylor, S., and F. X. Stewart: Distribution of Radio-iodine in human thyroid gland. Lancet 1951 II, 232.
Thode, G. H., C. H. Jaimet and S. Kirkwood: Studies and diagnostic tests of salivary and thyroid gland function with radioiodine. Proc. Radioisotope Conf. 1, 55 (1954).
Thode, G. H., C. H. Jaimet and S. Kirkwood: New England J. Med. 251, 129 (1954).
Thompson, W. O.: The present status of the treatment of toxic goiter. J. Clin. Endocrin. 12, 130 (1952).
Tighe, W. I.: Temporary hypoparathyroidism following radioactive iodine treatment for thyreotoxicosis. J. Clin. Endocrin. 12, 1220 (1952).
Tishkoff, G. H., R. Bennett, V. Bennett and L. L. Miller: Radioiodine and paper chromatography technique in the study of thyroid metabolism. Science (Lancaster, Pa.) 110, 452 (1949).
Trippel, O. H., G. E. Sheline, R. H. Moe and D. E. Clark: Clinical application of radioactive iodine in diseases of the thyroid. Med. Clin. N. Amer. 35, 37 (1951).
Trunnell, J. B., B. J. Duffy, J. T. Godwin, W. Peacock, L. Kirschner and R. Hill: The distribution of radioactive iodine in human tissues-Necropsy study in nine patients. J. Clin. Endocrin. 10, 1007 (1950).
Trunnell, J. B., L. D. Marinelli, B. L. Duffy, R. Hill, W. Peacock and R. W. Rawson: The treatment of metastatic thyroid cancer with radioactive iodine: Credits and debits. J. Clin. Endocrin. 9, 1138 (1949).
Trunnell, J. B., and P. Wade: Factors governing the development of the chick embryo thyroid. II. Chronology of iodinated compounds studied by chromatographic analysis. J. Clin. Endocrin. 15, 107 (1955).
Uotila, U. U.: The regulation of thyrotropic function by thyroxin after pituitary stalk section. Endocrinology (Springfield, 111.) 26, 129 (1940).
Vanderlaan, J. E., and W. P. Vanderlaan: The iodide concentrating mechanism of the rat thyroid and its inhibition by thiocyanate. Endocrinology (Springfield, 111.) 40, 403 (1947).
Vanderlaan, W. P., and A. Bissell: Effect of propylthiouracil and potassium thiocyanate on the uptake of iodine by the thyroid gland of the rat. Endocrinology (Springfield, 111.) 39. 157 (1946).
Vanderlaan, W. P., and M. A. Greer: Some effects of the hypophysis on iodine metabolism by the thyroid gland of the rat. Endocrinology (Springfield, 111.) 47, 36 (1950).
Vannotti, A., Et M. Closuit: Relations fonctionelles entre la thyroide et le système endocrinien étudiées à l’aide du test au radio-iode. Bull. Schweiz. Akad. Med. Wiss. 8, 476 (1952).
Verzár, F., and Y. Vidovic: The action of thyrotrophs hormone and cortisone on the uptake of I131 by the thyroid gland. J. of Endocrin. 8, 321 (1952).
Verzár, F., E. Sailer and V. Vidovic: Changes in thyroid activity at law atmospheric pressures and at high altitudes, as tested with I131. J. of Endocrin. 8, 308 (1952).
Vetter, H.: Die Diagnostik der Schilddrüsenerkrankungen mit radioaktivem Jod. Erg. inn. Med. 6, 695–790 (1955).
Visscher, M. De, G. B. Mcadams Et W. T. Salter: Emploi de l’iode radioactif dans la détermination de l’activité sécrétoire thyroidienne. Ann. d’Endocrin. 12, 573 (1951).
Warren, S.: A classification of tumors of the thyroid. Amer. J. Roentgenol. 46, 447 (1941).
Wayne. E. J.: The treatment of thyrotoxicosis with radioactive iodine. Proc. Roy. Soc. Med. 45, 338 (1952).
Wayne. E. J.: The diagnosis of thjTotoxicosis. Brit. Med. J. 19541, 411.
Wayne. E. J., A. G. Macgregor and G. W. Blomfield: Treatment of thyrotoxicosis with I131. Brit. Med. Bull. 8, 148 (1952).
Wegelin, C.: Die Schilddrüse, in: Handbuch der speziellen pathologischen Anatomie und Histologie. Bd. 8, pp. 175–176. Berlin: Julius Springer 1926.
Wegelin, C.: Die pathologische Anatomie der Struma maligna und der Kretinenschilddrüse. Ber. Internat. Kropfkonf. in Bern 1927. Bern: H. Huber 1928.
Weinbren, M.: Carcinom of the thyroid in children. S. Afric. J. Clin. Sci. 5, 179 (1954).
Weissbecker, L.: Krankheiten des endokrinen Systems und der Stoffwechselfunktion. In Lehrbuch der inneren Medizin. Berlin-Göttingen-Heidelberg: Springer-Verlag 1955.
Werner, S. C.: Results in treatment of hyperthyroidism writh radioiodine I131. Med. Clin. X. Amer. 1952, 623.
Werner, S. C., L. D. Goodwin and E. H. Quimby: The tracer technique wdth radioactive iodine, I131, as a potential substitute for the basal metabolic rate determination in routine clinical practice. J. Clin. Endocrin. 9, 664 (1949).
Werner, S. C., and C. Schmidt: Some results from use of radioactive iodine, I131, in diagnosis and treatment of toxic goiter. Amer. J. Roentgenol. 63, 889 (1950).
Werner, S. C., H. B. Hamilton, E. Leifer and L. D. Goodwin: An appraisal of the radioiodine tracer technic as a clinical procedure in the diagnosis of thyroid disorders. Uptake measurement directly over the gland and a note on the use of thyrotropin (TSH). J. Clin. Endocrin. 10, 1054 (1950).
Werner, S. C., and M. R. Nemeth: Therapeutic effects from repeated diagnostic doses of I131 in adult and juvenile hyperthyroidism. J. Clin. Endocrin. 12, 1349 (1952).
Werner, S. C., E. H. Quimby and C. Schmidt: Clinical experience in diagnosis and treatment of thyroid disorders with radioactive iodine. Radiology 51, 564 (1948).
Werner, S. C., E. H. Quimby and C. Schmidt: The use of tracer doses of radioactive iodine, I131, in the study of normal and disordered thyroid function in man. J. Clin. Endocrin. 9, 342 (1949).
Werner, S. C., E. H. Quimby and C. Schmidt: Radioactive iodine I131 in the treatment of hyperthyroidism. Amer. J. Med. 7, 731 (1949).
White, W. E., and W. A. Reilly: Chromatographic changes in plasma I131 during the treatment of Graves’ and cardiac diseases correlated with clinical course. J. Labor, a. Clin. Med. 43, 553 (1954).
Wichmann, F. W., U. P. Schmidt: Über die Beeinflussung der Luftröhre bei Strumen und die Bedeutung der röntgenologischen Voruntersuchungen für die Strumektomie. Chirurg 21. 280 (1950).
Williams, R. H., H. Jaffe and J. A. Taylor: Effect of halides thiocyanate and propylthiouracil upon the distribution of radioiodine in the thyroid gland, blood and urine. Amer. J. Med. Sci. 219, 7 (1950).
Williams, R. H., G. T. Towery, W. F. Rogers and R. Tagnon: Factors influencing the effectiveness of radioiodotherapeusis. Amer. J. Med. 7, 718 (1949).
Williams, R. H., B. T. Towery, H. Jaffe, W. F. Rogers and R. Tagnon: Radioiodotherapeusis. Amer. J. Med. 7, 702 (1949).
Wing, E. S., and S. P. Asper: Observations on the use of propylthiouracil in hyperthyroidism with especial reference to long term treatment. Bull. Johns Hopkins Hosp. 90, 201 (1952).
Winkler, C.: Aussichten der Behandlung maligner Strumen mit radioaktivem Jod. Dtsch. med. Wschr. 1950, 1438.
Winkler, C.: Radioaktives Jod zur Diagnose und Therapie von Schilddrusenerkrankungen. Strahlen-ther. 85, 126 (1951).
Winzler, R. J., and S. R. Notrica: Association of thyroxine with plasmaproteins. Federat. Proc. 11, 312 (1952).
Wolff, J., I. L. Chaikoff, A. Taurog and L. Rubin: The disturbance in iodine metabolism produced by thiocyanate: The mechanism of its goitrogenic action with radioactive iodine as indicator. Endocrinology (Springfield, 111.) 39, 140 (1946).
Wollman, S. H., and R. D. Scow: The effect of propylthiouracil on radioiodide concentrating, by the thyroid gland in normal and hypophysectomized mice. Endocrinology (Springfield, 111.) 53, 332 (1953).
Wyngaarden, J. B., J. B. Stanbury and B. Rapp: The effects of iodide, perchlorate, thiocyanate, and nitrate administration upon the iodide concentrating mechanism of the rat thyroid. Endocrinology (Springfield, 111.) 52, 568 (1953).
Wyngaarden, J. B., and C. H. Du Toit: On the mechanism of iodide accumulation by the thyroid gland. J. Clin. Endocrin. 11, 1259 (1951).
Wyngaarden, J. B., B. M. Wright U. P. Ways: The effect of certain anions upon the accumulating and reten-tion of iodide by the thyroid gland. Endocrinology (Springfield, 111.) 50, 537 (1952).
Zieve, L., B. Skanse and A. L. Schultz: Comparative value of the basal metabolic rate, chemical protein-bound iodine, and radioactive excretion or uptake in the diagnosis of borderline hyperthyroidism, when used individually or in combination. J. Labor, a. Clin. Med. 45, 281 (1955).
Zingg, W., and W. F. Perry: Influence of adrenal and gonadal steroids on the uptake of iodine by the thyroid gland. J. Clin. Endocrin. 13, 712 (1953).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1957 Springer-Verlag oHG. Berlin · Göttingen · Heidelberg
About this paper
Cite this paper
Keiderling, W. (1957). Therapie der Schilddrüse mit Radiojod. In: Heilmeyer, L., Schoen, R., Glanzmann, E., De Rudder, B. (eds) Ergebnisse der Inneren Medizin und Kinderheilkunde. Ergebnisse der Inneren Medizin und Kinderheilkunde, vol 8. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-94687-5_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-94687-5_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-94688-2
Online ISBN: 978-3-642-94687-5
eBook Packages: Springer Book Archive